Correlation Between Nuvalent and Orchestra BioMed

Can any of the company-specific risk be diversified away by investing in both Nuvalent and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nuvalent and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Nuvalent and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Orchestra BioMed.

Diversification Opportunities for Nuvalent and Orchestra BioMed

0.37

Correlation Coefficient

Nuvalent  Orchestra BioMed

Weak diversification

The 3 months correlation between Nuvalent and Orchestra is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Nuvalent i.e., Nuvalent and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Nuvalent and Orchestra BioMed

Given the investment horizon of 90 days Nuvalent is expected to generate 0.49 times more return on investment than Orchestra BioMed. However, Nuvalent is 2.04 times less risky than Orchestra BioMed. It trades about 0.04 of its potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about 0.02 per unit of risk. If you would invest  5,692  in Nuvalent on December 3, 2024 and sell it today you would earn a total of  1,411  from holding Nuvalent or generate 24.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nuvalent  vs.  Orchestra BioMed Holdings

Nuvalent

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Orchestra BioMed Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Nuvalent and Orchestra BioMed

The main advantage of trading using opposite Nuvalent and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.

The idea behind Nuvalent and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.